Aster Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.52K Sell
144
-16
-10% -$675 ﹤0.01% 733
2026
Q1
$3.42K Buy
+160
New +$7.62K ﹤0.01% 714
2025
Q3
Sell
-193
Closed -$4.93K 1264
2025
Q2
$4.93K Buy
+193
New +$4.21K ﹤0.01% 867
2025
Q1
Sell
-198
Closed -$4.16K 1575
2024
Q4
$4.16K Buy
+198
New +$4.58K ﹤0.01% 887

Other funds holding PAHC

Aster Capital Management's PAHC Position: Q2 2026 in Review

Aster Capital Management reduced its Phibro Animal Health (PAHC) stake by 10% in Q2 2026, selling an estimated $675 and leaving 144 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Aster Capital Management first reported a position in PAHC in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.93K in Q2 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Aster Capital Management held 144 shares of Phibro Animal Health worth $4.52K as of Q2 2026.
  • Aster Capital Management sold 16 Phibro Animal Health shares in Q2 2026, an estimated $675.
  • Phibro Animal Health made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #733 holding.
  • Aster Capital Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Phibro Animal Health position peaked at $4.93K in Q2 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.